Editorial: Post-translational modifications in human cancer: pharmacological insights and therapeutic opportunities.
作者信息
Chen Yongzhi, Fan Angelina W, Huang Lei
机构信息
Division of Innate Immunity, Department of Medicine, University of Massachusetts Chan Medical School, Westborough, MA, United States.
Westborough High School, Westborough, MA, United States.
出版信息
Front Pharmacol. 2025 Jul 7;16:1654659. doi: 10.3389/fphar.2025.1654659. eCollection 2025.
Abstract
摘要
相似文献
1
Editorial: Post-translational modifications in human cancer: pharmacological insights and therapeutic opportunities.
Front Pharmacol. 2025 Jul 7;16:1654659. doi: 10.3389/fphar.2025.1654659. eCollection 2025.
2
Post-translational modifications in diabetic retinopathy: a comprehensive review of mechanisms, crosstalk and clinical prospects.
Exp Eye Res. 2025 Oct;259:110534. doi: 10.1016/j.exer.2025.110534. Epub 2025 Jul 21.
3
Targeting post-translational modifications: novel insights into bone metabolic diseases.
J Adv Res. 2025 Jun 13. doi: 10.1016/j.jare.2025.06.020.
4
Protein post-translational modifications (PTM) unlocking resilience to abiotic stress in horticultural crops: A review.
Int J Biol Macromol. 2025 May;306(Pt 4):141772. doi: 10.1016/j.ijbiomac.2025.141772. Epub 2025 Mar 4.
5
Current Technologies Unraveling the Significance of Post-Translational Modifications (PTMs) as Crucial Players in Neurodegeneration.
Biomolecules. 2024 Jan 16;14(1):118. doi: 10.3390/biom14010118.
6
Short-chain acyl post-translational modifications in cancers: Mechanisms, roles, and therapeutic implications.
Cancer Commun (Lond). 2025 Jul 24. doi: 10.1002/cac2.70048.
7
Modifications in the cellular proteome and their clinical application.
Medicina (B Aires). 2019;79(Spec 6/1):570-575.
8
Dynamic regulators of ferroptosis: Post-translational modifications in ferroptotic cell death.
Pharmacol Res. 2025 Jul;217:107815. doi: 10.1016/j.phrs.2025.107815. Epub 2025 Jun 5.
9
Novel insights into lncRNAs as key regulators of post-translational modifications in cancer: mechanisms and therapeutic potential.
Cell Oncol (Dordr). 2025 Jul 2. doi: 10.1007/s13402-025-01086-1.
10
Crosstalk between SUMOylation and other post-translational modifications in breast cancer.
Cell Mol Biol Lett. 2024 Aug 10;29(1):107. doi: 10.1186/s11658-024-00624-3.
本文引用的文献
1
The impact of dysregulation SUMOylation on prostate cancer.
J Transl Med. 2025 Mar 6;23(1):286. doi: 10.1186/s12967-025-06271-2.
2
Regulation of ovarian cancer by protein post-translational modifications.
Front Oncol. 2024 Nov 29;14:1437953. doi: 10.3389/fonc.2024.1437953. eCollection 2024.
3
The role of histone post-translational modifications in cancer and cancer immunity: functions, mechanisms and therapeutic implications.
Front Immunol. 2024 Nov 15;15:1495221. doi: 10.3389/fimmu.2024.1495221. eCollection 2024.
4
Post-translational modifications and their implications in cancer.
Front Oncol. 2023 Sep 19;13:1240115. doi: 10.3389/fonc.2023.1240115. eCollection 2023.
5
Advances in post-translational modifications of proteins and cancer immunotherapy.
Front Immunol. 2023 Aug 22;14:1229397. doi: 10.3389/fimmu.2023.1229397. eCollection 2023.
6
Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation.
Cell. 2023 Aug 31;186(18):3945-3967.e26. doi: 10.1016/j.cell.2023.07.013. Epub 2023 Aug 14.
7
Emerging Roles of SIRT5 in Metabolism, Cancer, and SARS-CoV-2 Infection.
Cells. 2023 Mar 9;12(6):852. doi: 10.3390/cells12060852.
8
PRMT5 activates AKT via methylation to promote tumor metastasis.
Nat Commun. 2022 Jul 8;13(1):3955. doi: 10.1038/s41467-022-31645-1.
9
The Function of SUMOylation and Its Critical Roles in Cardiovascular Diseases and Potential Clinical Implications.
Int J Mol Sci. 2021 Sep 30;22(19):10618. doi: 10.3390/ijms221910618.
10
Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review.
JAMA. 2021 Feb 16;325(7):669-685. doi: 10.1001/jama.2021.0106.
Zotero 插件